The report will be delivered in 2-3 business days.

G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2020-30: COVID-19 Growth And Change

Starting Price : $ 4000.00 $3200.00 | Pages : 150 | Published : October 2020 | SKU CODE : 7739 | Format :


The G-CSF (Granulocyte Colony Stimulating Factors) market consists of sales of G-CSF drugs and relates services. Granulocyte colony-stimulating factor is a drug used to treat neutropenia, a disorder in which there is a lower-than-average number of white blood cells, caused by certain forms of chemotherapy.

The global Granulocyte-Colony Stimulating Factor (G-CSF) is expected to decline from $7.30 billion in 2019 to $6.91 billion in 2020 at a compound annual growth rate (CAGR) of -5.27%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $8.33 billion in 2023 at a CAGR of 6.44%.

North America was the largest region in the G-CSF market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The increasing prevalence of cancer is a key factor driving the growth of the G-CSF (Granulocyte Colony Stimulating Factors) market. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. According to the World Health Organization (WHO), 9.6 million deaths occurred in 2018 due to cancer. About 70% of deaths from cancer occur in low- and middle-income countries. G-CSF is a class of growth factor which produces white blood cells in the bone marrow to minimize the risk of infection and sepsis. In cancer patients, G-CSF accelerates recovery and reduces mortality from neutropenia after chemotherapy for cancer. It can also reduce infection after certain forms of treatment for cancer. Therefore, the increasing prevalence of cancer is expected to drive the growth of the G-CSF market.

The increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF) is another key factor driving the growth of the granulocyte-colony stimulating factor market. The prophylaxis with G-CSF decreases the occurrence of febrile neutropenia (FN), allowing patients to receive and stay on myelosuppressive chemotherapy. The current use of G-CSF prophylaxis offers significant benefits including reducing incidents of febrile neutropenia by 3.3 million and cases of chemotherapy reduced dosage intensity by less than 85%, over the next 10 years. Therefore, the increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF) is expected to drive the growth of the granulocyte-colony stimulating factor market.

The high cost is a key factor limiting the growth of the G-CSF market. Improved chemotherapy administration is responsible for the rise in instant medical expenses in breast cancer patients receiving primary prophylactic (PP) G-CSF. According to a study conducted by the American Journal of Managed Care, PPG-CSF administration in the first chemotherapy class was associated with a 57 % increase in total Medicare costs during the study period, despite a fall in medical costs for neutropenia. Around 42% of the increase can be attributed to the rise in the costs of chemotherapy. Each shot of PPG-CSF costs more than $250. Therefore, the high cost is expected to hinder the growth of the G-CSF (Granulocyte Colony Stimulating Factors) market.

In June 2019, Pfizer Inc., a US-based pharmaceutical corporation, acquired Array BioPharma Inc. for $48 per share in cash, for a total enterprise value of approximately $11.4 billion. This acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory, particularly in the long term. Array BioPharma Inc, a US-based company, is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

The global g-csf (granulocyte colony Stimulating factors) market is segmented -

1) By Type: Lenograstim (Granocyte), Filgrastim (Neupogen, Zarzio, Nivestim, Accofil), Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco), Lipegfilgrastim (Lonquex).

2) By Application: Oncological Diseases, Blood Disorders, Growth Hormone Deficiencies, Chronic and Autoimmune Disorders, Others.

The major players covered in the global g-csf (granulocyte colony stimutating factors) market are BioCad, Teva Pharmaceuticals, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Dong-A Socio Group, Amgen, Dr. Reddy`s Laboratories, Celltrion Inc., Emcure Pharmaceuticals.

The countries covered in the global g-csf (granulocyte colony stimutating factors) market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The regions covered in the global g-csf (granulocyte colony stimutating factors) market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    1. Executive Summary

    2. G-CSF (Granolocyte Colony Stimulating Factors) Market Characteristics

    3. G-CSF (Granolocyte Colony Stimulating Factors) Market Size And Growth

    3.1. Global G-CSF (Granolocyte Colony Stimulating Factors) Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global G-CSF (Granolocyte Colony Stimulating Factors) Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. G-CSF (Granolocyte Colony Stimulating Factors) Market Segmentation

    4.1. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Lenograstim (Granocyte)

    Filgrastim (Neupogen, Zarzio, Nivestim, Accofil)

    Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco)

    Lipegfilgrastim (Lonquex)

    4.2. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Oncological Diseases

    Blood Disorders

    Growth Hormone Deficiencies

    Chronic and Autoimmune Disorders

    Others

    5. G-CSF (Granolocyte Colony Stimulating Factors) Market Regional And Country Analysis

    5.1. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific G-CSF (Granolocyte Colony Stimulating Factors) Market

    6.1. Asia-Pacific G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    6.2. Asia-Pacific G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China G-CSF (Granolocyte Colony Stimulating Factors) Market

    7.1. China G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    7.2. China G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.3. China G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India G-CSF (Granolocyte Colony Stimulating Factors) Market

    8.1. India G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    8.2. India G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan G-CSF (Granolocyte Colony Stimulating Factors) Market

    9.1. Japan G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    9.2. Japan G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia G-CSF (Granolocyte Colony Stimulating Factors) Market

    10.1. Australia G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia G-CSF (Granolocyte Colony Stimulating Factors) Market

    11.1. Indonesia G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea G-CSF (Granolocyte Colony Stimulating Factors) Market

    12.1. South Korea G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe G-CSF (Granolocyte Colony Stimulating Factors) Market

    13.1. Western Europe G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    13.2. Western Europe G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK G-CSF (Granolocyte Colony Stimulating Factors) Market

    14.1. UK G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    14.2. UK G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany G-CSF (Granolocyte Colony Stimulating Factors) Market

    15.1. Germany G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France G-CSF (Granolocyte Colony Stimulating Factors) Market

    16.4. France G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.5. France G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe G-CSF (Granolocyte Colony Stimulating Factors) Market

    17.1. Eastern Europe G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    17.2. Eastern Europe G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia G-CSF (Granolocyte Colony Stimulating Factors) Market

    18.1. Russia G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America G-CSF (Granolocyte Colony Stimulating Factors) Market

    19.1. North America G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    19.2. North America G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA G-CSF (Granolocyte Colony Stimulating Factors) Market

    20.1. USA G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    20.2. USA G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America G-CSF (Granolocyte Colony Stimulating Factors) Market

    21.1. South America G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    21.2. South America G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil G-CSF (Granolocyte Colony Stimulating Factors) Market

    22.1. Brazil G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East G-CSF (Granolocyte Colony Stimulating Factors) Market

    23.1. Middle East G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    23.2. Middle East G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa G-CSF (Granolocyte Colony Stimulating Factors) Market

    24.1. Africa G-CSF (Granolocyte Colony Stimulating Factors) Market Overview

    24.2. Africa G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. G-CSF (Granolocyte Colony Stimulating Factors) Market Competitive Landscape And Company Profiles

    25.1. G-CSF (Granolocyte Colony Stimulating Factors) Market Competitive Landscape

    25.2. G-CSF (Granolocyte Colony Stimulating Factors) Market Company Profiles

    25.2.1. BioCad

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Teva Pharmaceuticals

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Pfizer

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Intas Pharmaceuticals

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Novartis AG

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The G-CSF (Granolocyte Colony Stimulating Factors) Market

    27. G-CSF (Granolocyte Colony Stimulating Factors) Market Trends And Strategies

    28. G-CSF (Granolocyte Colony Stimulating Factors) Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Asia-Pacific, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: China, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: China, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: India, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: India, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Japan, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Japan, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Australia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Australia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Indonesia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: South Korea, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: Western Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: UK, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: UK, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Germany, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Germany, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: France, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: France, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: Eastern Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: Russia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: Russia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: North America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: North America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: USA, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: USA, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: South America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: South America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: Brazil, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: Middle East, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Africa, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Africa, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: BioCad Financial Performance
  • Table 46: Teva Pharmaceuticals Financial Performance
  • Table 47: Pfizer Financial Performance
  • Table 48: Intas Pharmaceuticals Financial Performance
  • Table 49: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Asia-Pacific, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: China, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: China, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: India, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: India, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: Japan, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Australia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Indonesia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: South Korea, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: Western Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: UK, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: UK, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Germany, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: France, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: France, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: Eastern Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: Russia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: North America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: North America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: USA, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: USA, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: South America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: South America, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: Brazil, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: Middle East, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Africa, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: BioCad Financial Performance
  • Figure 46: Teva Pharmaceuticals Financial Performance
  • Figure 47: Pfizer Financial Performance
  • Figure 48: Intas Pharmaceuticals Financial Performance
  • Figure 49: Novartis AG Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)